Actively Recruiting
Efficacy of Three Dimensional Transesophageal Echocardiography for Percutaneous Device Closure in Atrial Septal Defect
Led by Asan Medical Center · Updated on 2025-02-07
100
Participants Needed
1
Research Sites
665 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Background: Three-dimensional echocardiographic image for atrial septal defect (ASD) is useful for evaluation of defect size and shape. The investigators suggested optimal device size using three-dimensional transesophageal echocardiographic image and our formula in previous study. Purpose: In this study, the investigators seek to predict the correct device size and confirm the accuracy of the formula that we made before device closure in ASD patients.
CONDITIONS
Official Title
Efficacy of Three Dimensional Transesophageal Echocardiography for Percutaneous Device Closure in Atrial Septal Defect
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Indication for atrial septal defect closure
- Potential candidate for device closure
You will not qualify if you...
- Poor candidate for device closure due to multiple atrial septal defects or similar conditions
- Presence of other heart diseases needing open heart surgery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Asan Medical Center
Seoul, South Korea, 138-736
Actively Recruiting
Research Team
J
Jong-Min Song, MD,PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here